RIM
CLB icon

Reliant Investment Management’s Core Laboratories CLB Stock Holding History

Reliant Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,250
Closed -$476K – 63
2014
Q3 		$476K Hold
3,250
– – 0.44% 49
2014
Q2 		$543K Buy
3,250
+200
+7% +$35.6K 0.49% 47
2014
Q1 		$605K Hold
3,050
– – 0.57% 48
2013
Q4 		$582K Buy
+3,050
New +$568K 0.56% 45

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Reliant Investment Management's CLB Position: Q4 2014 in Review

Reliant Investment Management sold out of Core Laboratories (CLB) in Q4 2014, closing a stake of 3,250 shares — an estimated $476K sold.

Reliant Investment Management first reported a position in CLB in Q4 2013 and held it in 4 quarters. The position peaked at $605K in Q1 2014. 345 funds tracked by Wall St. Rank hold CLB as of Q4 2014.

  • Reliant Investment Management reported no remaining Core Laboratories position as of Q4 2014 after selling out during the quarter.
  • Reliant Investment Management sold 3,250 Core Laboratories shares in Q4 2014, an estimated $476K.
  • Reliant Investment Management first reported a position in Core Laboratories in Q4 2013 and held it in 4 quarters.
  • Reliant Investment Management's Core Laboratories position peaked at $605K in Q1 2014.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2014.

Based on Reliant Investment Management's 13F filing for Q4 2014, filed 17 Feb 2015.